Riskpilot← Back to searchSign inGet full accessAdjuvansa AB
ABIn liquidationOrg 5568427750Business and other management consultancy activities · NACE 7022Est. 20110 employees
Revenue 2022
SEK 10K
EBITDA margin
-67.2%
+80% vs 2021
Equity ratio
55.4%
Financial strength
Net profit 2022
SEK 25K
-73% vs 2021
| Revenue | SEK 10K | — |
| EBITDA | SEK -7K | +80% |
| Net profit | SEK 25K | -73% |
| Total assets | SEK 161K | -55% |
| Equity | SEK 89K | -62% |
| Employees | 0 | — |
Legal name
Adjuvansa AB
Org number
5568427750
Legal form
Aktiebolag
NACE code
7022 · Business and other management consultancy activities
Founded
22 februari 2011
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2022-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av likvidatorn externa firmatecknaren
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultverksamhet för företag och organisationer i syfte att systematisera deras arbete i enlighet med föreskrifter och standarder gällande kvalitet, arbetsmiljö och yttre miljö samt därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 142 | 124 | 44 | 0 | 10 |
| Staff expenses | — | — | — | — | −0 |
| EBITDA | 68 | 54 | 9 | −34 | −7 |
| Depreciation & amort. | −3 | −5 | −5 | −5 | — |
| EBIT | 65 | 49 | 4 | −39 | −7 |
| Net financials | — | — | — | — | 0 |
| Profit before tax | 84 | 59 | 27 | 122 | 32 |
| Tax | −19 | −13 | −6 | −27 | −7 |
| Net profit | 65 | 46 | 21 | 95 | 25 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 533 | 503 | 443 | 356 | 161 |
| Equity | 213 | 183 | 159 | 234 | 89 |
| Long-term debt | 0 | 0 | 0 | 0 | — |
| Short-term debt | 88 | 97 | 84 | 83 | 72 |
| Total debt | 88 | 97 | 84 | 83 | 72 |
EBITDA margin
-67.2%
This company
15.8%
Market median
-525% vs market
20182022
Equity ratio
55.4%
This company
38.2%
Market median
+45% vs market
20182022
Return on equity
28.3%
This company
18.4%
Market median
+54% vs market
20182022
Net profit margin
251.9%
This company
8.1%
Market median
+3010% vs market
20182022
Asset turnover
0.06×
This company
1.12×
Market median
-95% vs market
20182022
Debt / equity
0.81×
This company
0.62×
Market median
+31% vs market
20182022
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
UG Liquidator | Liquidator | 2022 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Board of Directors | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Adjuvansa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulf Gustaf Ludvigsson | Liquidator | 0 companies |
| Bengt Åke Georg Botvalde | Board of Directors | 0 companies |
| Ingrid Marianne Botvalde | Deputy Board Member | 0 companies |